Area of research
Hepatology · Surgery
Research interest
Research interests include Hepatocellular Carcinoma Treatment and Prognosis, Organ Transplantation Techniques and Outcomes, Liver Disease Diagnosis and Treatment, and Cholangiocarcinoma and Gallbladder Cancer Studies.
The Lancet Commission on addressing the global hepatocellular carcinoma burden: comprehensive strategies from prevention to treatment
Adjuvant and neoadjuvant immunotherapies in hepatocellular carcinoma
Intention-to-treat outcomes of patients with hepatocellular carcinoma receiving immunotherapy before liver transplant: The multicenter VITALITY study
Antiviral Therapy Utilization and 10-Year Outcomes in Resected Hepatitis B Virus– and Hepatitis C Virus–Related Hepatocellular Carcinoma
Intratumoral dendritic cell–CD4+ T helper cell niches enable CD8+ T cell differentiation following PD-1 blockade in hepatocellular carcinoma
Incidence and Risk Factors for Hepatocellular Carcinoma in Cirrhosis: The Multicenter Hepatocellular Carcinoma Early Detection Strategy (HEDS) Study
Novel Benchmark Values for Open Major Anatomic Liver Resection in Non-cirrhotic Patients
Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma
Ten-Year Outcomes of Liver Transplant and Downstaging for Hepatocellular Carcinoma
Integrated use of PD-1 inhibition and transarterial chemoembolization for hepatocellular carcinoma: evaluation of safety and efficacy in a retrospective, propensity score-matched study
Perihilar Cholangiocarcinoma – Novel Benchmark Values for Surgical and Oncological Outcomes From 24 Expert Centers
A human liver cell-based system modeling a clinical prognostic liver signature for therapeutic discovery
Development and validation of an individualized prediction calculator of postoperative mortality within 6 months after surgical resection for hepatocellular carcinoma: an international multicenter study
Trial Design and Endpoints in Hepatocellular Carcinoma: AASLD Consensus Conference
Intratumoral heterogeneity and clonal evolution in liver cancer
MRI radiomics features predict immuno-oncological characteristics of hepatocellular carcinoma
Targeting clinical epigenetic reprogramming for chemoprevention of metabolic and viral hepatocellular carcinoma
Direct-Acting Antiviral Therapy Not Associated With Recurrence of Hepatocellular Carcinoma in a Multicenter North American Cohort Study
Defining and predicting early recurrence after liver resection of hepatocellular carcinoma: a multi-institutional study
Hepatocellular carcinoma detection in liver cirrhosis: diagnostic performance of contrast-enhanced CT vs. MRI with extracellular contrast vs. gadoxetic acid
GALAD Score for Hepatocellular Carcinoma Detection in Comparison with Liver Ultrasound and Proposal of GALADUS Score
Is it Time to Abandon the Milan Criteria?
Sex difference in recurrence and survival after liver resection for hepatocellular carcinoma: A multicenter study
Improved Performance of Serum Alpha-Fetoprotein for Hepatocellular Carcinoma Diagnosis in HCV Cirrhosis with Normal Alanine Transaminase
Global patterns of hepatocellular carcinoma management from diagnosis to death: the <scp>BRIDGE</scp> Study
Ectopic lymphoid structures function as microniches for tumor progenitor cells in hepatocellular carcinoma
The role of hepatic resection in the treatment of hepatocellular cancer
Massive parallel sequencing uncovers actionable FGFR2–PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma
Integrative Molecular Analysis of Intrahepatic Cholangiocarcinoma Reveals 2 Classes That Have Different Outcomes
Concurrent sunitinib and stereotactic body radiotherapy for patients with oligometastases